MedPath

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

Recruiting
Conditions
COVID-19 Infection
Interventions
Other: Questionnaire Administration
Registration Number
NCT04491292
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may allow for more comprehensive actions to be taken to protect the mental health of employees.

Detailed Description

PRIMARY OBJECTIVE:

I. To assess psychosocial and stress-related outcomes in employees at MD Anderson Cancer Center during and post the COVID-19 pandemic.

SECONDARY OBJECTIVE:

I. To identify demographic and occupational factors associated with COVID-19 related psychosocial and stress outcomes.

OUTLINE:

Participants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20000
Inclusion Criteria
  • MD Anderson employees
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Observational (questionnaire)Questionnaire AdministrationParticipants complete 2 online questionnaires over 10 minutes each at baseline and at 3 months after the pandemic ends.
Primary Outcome Measures
NameTimeMethod
Change in stress-related outcomesBaseline up to 3 months after the outbreak ends

Will be assessed using the questions administered in the second part of the questionnaire, specifically, the 20 stress-related items and the IES. Summary statistics will be calculated for each of the individual 20 stress-related questions. The total distress score as well as the scores for the intrusion and avoidance subscales will be calculated and also summarized via descriptive statistics. Summary statistics will be calculated separately for data collected during the pandemic and at follow-up, as well as for change from pandemic to follow-up. Ninety-five percent confidence intervals will be calculated for the mean of the change scores.

Change in psychosocial outcomesBaseline up to 3 months after the outbreak ends

Will be assessed using the questions administered in the second part of the questionnaire, specifically, the 20 stress-related items and the Impact of Event Scale (IES). Summary statistics will be calculated for each of the individual 20 stress-related questions. The total distress score as well as the scores for the intrusion and avoidance subscales will be calculated and also summarized via descriptive statistics. Summary statistics will be calculated separately for data collected during the pandemic and at follow-up, as well as for change from pandemic to follow-up. Ninety-five percent confidence intervals will be calculated for the mean of the change scores.

Secondary Outcome Measures
NameTimeMethod
Demographic and occupational factors associated psychological and stress-related outcomesUp to 3 months

Summary statistics will also be calculated for demographic variables as well as all other questionnaire items. Ninety-five percent confidence intervals will also be calculated for the mean change from the pandemic scores. Summary statistics will also be calculated for subgroups of interest, such as occupation, age, etc. Two-sided two-sample t-tests, analysis of variance or Pearson/Spearman correlation coefficients, as applicable, will be used to determine whether different subgroups are differentially impacted by, or whether different levels of demographics (such as age) or occupational factors (such as years of service at MD Anderson and number of hours worked per week) are associated with, the COVID-19-related stress, with the stress being measured by the total distress score calculated from the IES as well as by the intrusion and avoidance scores, separately during and after the pandemics.

Trial Locations

Locations (1)

M D Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath